单位：[1]Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing (100007), China[2]Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou (730000), China[3]Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou (730000), China[4]Chinese GRADE Center, Lanzhou (730000), China[5]China School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR (999077), China[6]Department of Clinical Pharmacology, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin (300193), China[7]Department of Gastroenterology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing (100091), China[8]State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao (999078), China[9]Department of Acupuncture and Moxibustion, Wuxi People's Hospital, Jiangsu (214023), China[10]Chinese Cochrane Centre, West China Hospital, Sichuan University, Chengdu (610041), China四川大学华西医院[11]Division of Plastic Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University, Taipei (106), China[12]Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing (100700), China[13]Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, Beijing (100029), China
How to test the treatments of Chinese medicine (CM) and make them more widely accepted by practitioners of Western medicine and the international healthcare community is a major concern for practitioners and researchers of CM. For centuries, various approaches have been used to identify and measure the efficacy and safety of CM. However, the high-quality evidence related to CM that produced in China is still rare. Over the recent years, evidence-based medicine (EBM) has been increasingly applied to CM, strengthening its theoretical basis. This paper reviews the past and present state of CM, analyzes the status quo, challenges and opportunities of basic research, clinical trials, systematic reviews, clinical practice guidelines and clinical pathways and evidence-based education developed or conducted in China, pointing out how EBM can help to make CM more widely used and recognized worldwide.
基金：
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81430098, 81273935, 81503459]
第一作者单位：[1]Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing (100007), China[2]Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou (730000), China[3]Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou (730000), China[4]Chinese GRADE Center, Lanzhou (730000), China
通讯作者：
推荐引用方式(GB/T 7714)：
CHEN Yao-long,ZHAO Chen,ZHANG Li,et al.Toward Evidence-Based Chinese Medicine: Status Quo, Opportunities and Challenges[J].CHINESE JOURNAL of INTEGRATIVE MEDICINE.2018,24(3):163-170.doi:10.1007/s11655-017-2795-2.
APA：
CHEN Yao-long,ZHAO Chen,ZHANG Li,LI Bo,WU Chuan-hong...&SHANG Hong-cai.(2018).Toward Evidence-Based Chinese Medicine: Status Quo, Opportunities and Challenges.CHINESE JOURNAL of INTEGRATIVE MEDICINE,24,(3)
MLA：
CHEN Yao-long,et al."Toward Evidence-Based Chinese Medicine: Status Quo, Opportunities and Challenges".CHINESE JOURNAL of INTEGRATIVE MEDICINE 24..3(2018):163-170
